We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp. Class A Common Stock

Delisted

DALS was delisted on the 28th of July, 2023.

Fund managers haven’t disclosed any holdings of DALS yet.

DALS Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q3 2023, worth a combined $0 — down 100% from $177M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of DALS and 0 opened new positions — a net loss of 50 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was First Trust Capital Management, exiting entirely with an estimated $24.2M sold.

  • 0 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q3 2023, down from 50 in Q2 2023.
  • Funds reported $0 of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q3 2023 and 50 closed out, a net change of -50 holders.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q3 2023 was First Trust Capital Management, an estimated $24.2M sold.

Based on aggregated 13F filings for Q3 2023.